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Abstract. Organisations who operate in the safety critical domains such as the
medical device, avaition, and automotive domains must ensure their software is
safe and provide objective evidence to this effect. One way of achieving this is
by adhering to domain specific regulations and guidelines which specify a
comprehensive implementation of traceability. However there is a gap between
regulatory traceability requirements and what is implemented in practice. This
lack of compliance means that organisations find it difficult to assess the safety
of their software and thus ensure its safety. One reason for non-compliance with
regards to traceability is a lack of guidance on what traceability to implement or
how to implement it. In this paper we present the development and validation of
a roadmap for the implementation of traceability in the medical device domain.
The roadmap will provide medical device organisations with a pathway for
effective traceability implementation.
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1 Introduction
Developing software in the safety critical domain is a difficult task as manufactur-
ers must comply with numerous regulations and guidelines. Additionally, it is incum-
bent on the manufacturers of such software to prove that their software is safe. This
involves submission of a safety case which is a reasoned argument supported with
objective evidence proving that the software is safe for its intended use [1]. Establish-
ing effective software development processes that are based on recognised engineer-
ing principles appropriate for safety critical systems will greatly contribute towards
the safety of the software. At the heart of such processes they must incorporate trace-
ability.
Traceability is the ability to establish links (or traces) between source artefacts and
target artefacts [2]. Tracing, which is the process of developing traces, is an important
technique that can help to ensure that the right system is being designed and imple-
mented. It is important to implement "just the right amount" of traceability in "just the
right way" so that the risk-to-reward ratio benefits a project's circumstances. Other-
wise, you may find that:
1. A project suffers from excessive overhead without commensurate quality im-
provement.
2. The project fails to deliver the requisite quality
Neither of these outcomes is desirable therefore it is beneficial to define and im-
plement the right traceability strategy from the beginning. In the medical device do-
main, the “right amount” of traceability is determined by the medical device standards
and guidelines. These standards require traceability between each phase of the Soft-
ware Development Lifecycle (SDLC), Risk Management and Change Management
processes, e.g. traceability between software requirements and software architectural
design. This standards’ traceability requirements ensure verification of inputs to out-
puts. Additionally, the “right way” is influenced by traceability best practices.
However despite the regulatory requirements for traceability and the many benefits
it has to offer, most existing software systems lack explicit traceability links between
artefacts [3] and required phases. This leads to difficulties in verifying and validating
the software. Numerous reasons have been identified for reluctance in implementing
traceability, including a lack of guidance in terms of what traces to implement and
how to implement them. As a result practitioners are ill informed as to how best to
accomplish this task [4, 5]. To assist medical device organisations in addressing the
lack of guidance on how to implement effective traceability, this paper presents the
development and validation of a traceability roadmap.
While there is no standard definition of a roadmap, many definitions do exist, for
example a roadmap is ‘the view of a group of stakeholders as to how to get where they
want to go to achieve their desired objective’[6], or a roadmap is ‘a series of mile-
stones, comprised of goals, that will guide an organisation, through the use of specific
activities, towards compliance with regulatory standards’[7]. In effect a roadmap is a
plan that allows organisations put solutions in place in order to achieve specific goals.
The remainder of this paper is structured as follows: Section 2 outlines various
types of roadmaps and roadmap development methodologies while Section 3 outlines
the development methodology used to develop the roadmap presented in this paper.
Section 4 details the structure of the developed roadmap while Section 5 presents
the findings of an expert evaluation of the roadmap and a discussion of those findings,
while Section 6 concludes the paper.
2 Related Work
Robert Phaal et al., [8] leading authorities in the world of roadmapping (the pro-
cess of developing a roadmap), examined approximately 40 roadmaps and categorised
them into 8 types of roadmap (in terms of purpose) and 8 formats of roadmap (in
terms of graphical format). Based on the purpose that they serve, the following 8
types of roadmap have been identified: Product planning; Service/capability planning;
Strategic planning; Long range planning; Knowledge asset planning; Program plan-
ning; Process planning; and Integration planning. Based on the graphical format, the
following 8 formats of roadmap have been identified: Multiple layers; Single layer;
Bars; Tables; Graphs; Pictorial representations; Flow Charts; and Text.
Phaal et al. note that a range of roadmaps observed may be partially due to a lack
of an accepted standard for roadmap development, or may be due to the fact that or-
ganisations need to adapt their approach to suit their particular situation i.e. business
purpose, available resources etc. The authors also note that roadmaps can contain
elements of more than one type of roadmap resulting in many hybrid forms of
roadmap, which can result in organisations finding them difficult to use.
As a result of challenges organisations encountered when developing roadmaps Phaal
et al. developed a fast start approach called T-Plan to support the rapid initiation of
roadmapping [9]. These challenges included: keeping the roadmapping process
"alive" on an ongoing basis; starting up the process; and developing a robust method.
The T-Plan approach is based on four facilitated workshops. The first workshop
("Market") aims to establish a set of prioritized market and business drivers for the
future, reflecting external and internal factors. The second workshop ("Product") aims
to establish a set of "product feature concepts" that could satisfy the drivers identified
in Workshop 1. The third workshop ("Technology") aims to identify possible techno-
logical solutions that could deliver the desired product features. The fourth workshop
("Charting") draws the marketing and technology strands together to produce the first
roadmap. Its format is defined in terms of time scales, levels and product strategy.
The Software Engineering Institute in collaboration with Carnegie Mellon Univer-
sity and the Hewlett-Packard Company have developed a Software Process Improve-
ment (SPI) Roadmap [10]. This roadmap is a generic long range integrated plan for
initiating and managing a SPI program. Its purpose is to provide a generic description
of the steps involved in implementing a SPI program, at both a strategic level and an
operational level. The roadmap describes a process improvement program that occurs
in three phases, made up of six major activities within these phases. The three phases
are analogous to the SEI’s IDEAL model (Initiating, Diagnosing, Establishing, Acting
and Learning) for software process improvement. The phases are:
 Initiate process improvement;
 Baseline the current processes and opportunities;
 Implement process improvement by developing and sustaining improve-
ments within the organization.
Flood et al., [11] have developed a SPI roadmap for the implementation of medi-
cal device standards. The goal of this roadmap is to implement the processes neces-
sary to meet the requirements of specific medical device standards, and not to im-
prove existing processes as in traditional SPI models. The methodology used to de-
velop the roadmap is similar to the methodology used by Barafort et al., [12] for the
construction of ISO/IEC 15504-2 [13]compliant process assessment and process ref-
erence models. The methodology contains seven steps as follows:
1. Identify requirements of the standards;
2. Logically group all goals;
3. Separate grouped goals in line with ISO/IEC 15504 capability levels. These
grouped goals form milestones;
4. Order the milestones based on capability levels and logical groupings;
5. Validate the generated roadmap;
6. Identify activities that can meet the identified goals;
7. Validate activities in host organisation.
While there are numerous publications on roadmap development methodologies [14-
17] , the most common methodology is a three phase approach: an initiation phase
which includes defining the scope and boundaries of the technology roadmap, a de-
velopment phase, and a follow up phase which includes roadmap validation and im-
plementation plan.
3 Methodology
To develop a roadmap it is necessary to answer the following three questions:
Where are we now? Where are we going? and How do we get there?
The objective of this roadmap is to provide a pathway for the implementation of
traceability in a manner which is compliant with the medical device standards re-
quirements for traceability, and also to provide a pathway that adopts the best practic-
es for traceability implementation. These requirements and best practices provide an
answer to the question ‘Where are we going?’ An analysis of the medical device
standards (which included ISO/IEC 62304 [18], ISO/IEC 14971[19], ISO/IEC 13485
[20], and the FDA guidance documents [21-23]) yielded 26 requirements for tracea-
bility. These requirements were then transformed into a ISO/IEC 15504-2 [13] com-
pliant process assessment and process reference model using the TIPA transformation
process [12]. The application of this process assessment model (PAM), developed
prior to this roadmap [24], provides a baseline of an organisation’s current state with
regards to traceability and answers the question ‘Where are we now?’. To determine
the best practices for implementing traceability a literature review was conducted
which yielded 23 best practices [25]. These 23 best practices were categorised under
the 6 headings of: Traceability Policy; Traceability Information Model; Resources;
Appropriate Techniques; Standard Operating Procedure and Communication Method.
Now that the requirements and best practices for traceability implementation were
identified a decision as to the type and format of the roadmap was required. In con-
templating the taxonomy of roadmap types and formats identified by [8] it was con-
sidered that the traceability roadmap aligned with the ‘Process planning’ type of
roadmap. This type supports the management of knowledge, focusing on knowledge
flows that are needed to facilitate effective traceability implementation. In addition to,
and perhaps more important than roadmap type, the format of the roadmap was then
considered. It was decided that the roadmap should be a hybrid version entailing both
the ‘single layer’ and ‘text’ formats. This hybrid version was chosen for the following
reasons:
 Combinations of pictorial information with text-only information facilitate
significant improvements in understanding [26];
 The single layer roadmap is a graphical format and can present a lot of in-
formation in a readily understandable format;
 The traceability roadmap needed to present a lot of information such as base
practices and the benefits that an organisation could leverage through each
phase of the implementation. In addition, it was felt that an implementation
case study would be of great benefit to organisations that do not have exper-
tise in the area of traceability. Therefore it was decided that the best way to
present this information would be in text format.
4 Roadmap Overview
The roadmap contains three separate sections. Section 1 contains an overview (see
Figure 1) of the steps an organization should take when implementing an effective
traceability process. During the pre-production stage ‘Plan for Traceability’, an
organisation should decide at an organisation level, or the project manager should
decide at the project level which of the traceability best practices to implement. The
best practices are numbered from 2.4.1 to 2.4.6 and this is the suggested order of im-
plementation as there are certain dependencies between them, for example the Trace-
ability Information model details the traces to be implemented and this information
should be known before deciding on required resources.
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The Production stage in Figure 1 indicates implementation of traceability through
the Software Development Lifecycle (SDLC) and the supporting processes of Risk
Management and Change Management. The SDLC, Risk Management and Change
Management processes respectively contain 14, 7 and 4 base practices (as distinct
from best practices identified in Pre-Production). Figure 1, indicates at what stage
during these processes the base practices should be exercised. These base practices
have been extracted from the traceability PAM developed in conjunction with this
roadmap [24]. Risk Management and thus risk management traceability should be
implemented at each stage of the SDLC and through the maintenance lifecycle
whereas Change Management and thus change management traceability should be
implemented whenever a change is required through the SDLC and maintenance
lifecycle.
Traceability needs to be maintained throughout Production and Post-Production
or it will degrade and become untrustworthy. Maintaining traceability through Post-
Production requires exercising the same development processes (i.e. SDLC, Risk
Management and Change Management) and same base practices exercised during the
production stage.
Section 2 of the roadmap contains details of the base practices for implementing
traceability through the SDLC, Change Management, and Risk Management process-
es in addition to the best practices for implementing traceability. These base practices,
are the activities that contribute to achieving the effective implementation of tracea-
bility through the SDLC, Risk Management and Change Management processes. For
example Base Practice 1 (BP1) of the SDLC is: Establish bi-directional traceability
between System requirement and their source.
Section 3 of the roadmap contains an implementation case study which guides the
reader through the implementation of traceability in a fictional organization and is
thought to be of particular benefit to organisations with little experience in software
process improvement or implementation of traceability.
Figure 1 also indicates the benefits that can be leveraged during the SDLC and sup-
porting processes of risk management and change management e.g. benefits 4, 7 and
8 can be leveraged through Risk Management traceability. The benefits are:
Benefit 1: Maintenance. Accurate traceability information facilitates making chang-
es correctly and completely during maintenance, thus improving productivity.
Benefit 2: Reuse of components. The traceability matrices facilitate reusing product
components from past projects and thus increasing productivity.
Benefit 3: Impact Analysis. Traceability information can be used to quickly and
accurately identify the impact of any proposed change to the system.
Benefit 4: Project Management. Traceability information allows project managers
to have current data on the progress of the project. By analysing the traceability ma-
trices, the project manager can quickly determine which artefacts have been imple-
mented and thus determine if schedule is on target.
Benefit 5: Customer confidence. The traceability matrices can be presented to the
customer as reassurance that the customer is getting the product that they requested.
Benefit 6: Verification and Validation. The SDLC traceability matrix can be used to
prove that a requirement has been designed into the system and implemented in the
code. This validates the requirement. Similarly the trace matrix can be used to prove
that the requirement, design and code have been tested which verifies the require-
ment, design and code.
Benefit 7: Certification. Regulation normally requires critical systems are certified
before entering service. This involves submission of a safety case. A good safety case
encompasses an effective risk mitigation process which is highly dependent on re-
quirements traceability.
Benefit 8: Key personnel leaving. Documenting the links between artefacts through
the traceability matrices reduces the risks of information being lost if key personnel
leave the project/organisation.
Benefit 9: Test failures. If tests fail, the SDLC traceability matrix can be used to
identify the artefacts that potentially cause the failures, as requirements, design and
code are linked to software requirements test.
5 Validation of the Roadmap
5.1 Research Method
An initial validation of the traceability roadmap has been conducted by expert re-
view. Eight experts agreed to participate and were chosen based on their expertise in
one or more of the following: a) roadmap development, b) medical device standards,
c) requirements traceability, d) medical device software development and e) software
process improvement. A brief overview of the experts credentials include:
Expert 1 has seven years in industry and seven years in academia researching
traceability;
Expert 2 has more than thirty years’ experience in software development, is a con-
sultant of a major medical device manufacturer, is a member of the ISO/IEC JTC1
WG10 (Process assessment), and is the author of the addendum of IEC 62304:2006
showing the mapping between 62304 and 12207;
Expert 3 has worked in the software industry for about 12 years as programmer,
analyst, project manager and database administrator and is Chief Scientist with a ma-
jor software research centre;
Expert 4 has forty years’ experience in software development, the last ten of
which have been in medical device software specialising in integration of traceability;
Expert 5 has twenty years’ experience in software development in roles such as
Quality manager, and Lean and Agile coach. He has established a UML modelling
concept to support 100% traceability;
Expert 6 has managed software design and development processes for a medical
device manufacturer. This role included oversight of software quality assurance;
Expert 7 develops software for laboratory testing in a medical device company
and has experience with tests and requirements traceability according to IEC 62304;
Expert 8 has experience in industry software development, open source software
development and roadmap development.
Each reviewer was sent a copy of the roadmap along with a questionnaire which
focused on the roadmaps ‘fit for purpose’. Some of the questions asked for an opinion
based on the 5 level Likert scale [27] including a rationale for their response, while
some of the questions asked for an opinion (without the Likert scale) and a rationale
for their opinion. The questions requiring a Likert scale response are listed in Table 1.
An example of a question without the Likert scale asked in the questionnaire is: Do
you agree with the order of implementation depicted in Figure 1? Please give a short
rationale for your opinion.
After all responses were received they were tabulated and a focus group consisting
of four members from the Regulated Software Research Centre based in Dundalk
Institute of Technology, Ireland was then convened to discuss the responses and ar-
rive at a general consensus as to what changes should be made to the roadmap.
5.2 Findings
The eight experts were asked three questions which required a response rated on a
five point Likert scale where 1 = Strongly Disagree, 2 = Disagree, 3 = Neither Agree
or Disagree, 4 = Agree and 5 = Strongly Agree. The questions and responses are
shown in Table 1.
Table 1. Reviewers responses rated on Likert scale
Questions Rating
1 2 3 4 5
To what extent do you agree that the traceability
implementation roadmap is usable in practice?
2 1 3 2
To what extent do you agree that the traceability
roadmap is adaptable and customisable to different
company settings (size, culture, resources etc.)?
1 2 5
To what extent do you agree that the traceability
roadmap is useful in practice?
1 2 4 1
The table indicates for example that in response to the question, ‘To what extent do
you agree that the traceability implementation roadmap is usable in practice?’, two
reviewers strongly agreed that it did while three reviewers agreed that it did etc. So
while the table indicates an overall positive response, a series of further questions in
the questionnaire elicited a total of 42 comments/suggestions for improvement. These
comments were categorized under three main headings of Structure, Content, and
Rationale as shown in Table 2.
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Comments
4 1 2 6 6 1 2 3 5 6 1 3 1 1
The Structure category contained 7 comments about the structure of the roadmap.
These comments related to:
• the order of the best practices under Pre-Production in Figure 1;
• a comment stating that references to medical device standards should be in
an Appendix;
• 2 comments stating that the benefits of traceability should be in the introduc-
tion.
The majority of received comments were categorized under the Content category.
This category contains 29 comments which were generally focused on the substance
of the roadmap. These comments related to:
• Six comments stated that they thought the roadmap had too much content
and was too complex e.g. “I would have like to make it much shorter with
better visualizations”.
• Six comments were also made with regard to tools and automation, suggest-
ing that while the roadmap offers both automated and manual options, the
roadmap would be better served if it ‘encourages automation more’.
• One comment on implementation detail suggests that a better explanation of
how to complete matrices is required;
• Three comments suggested that a number of additional benefits of traceabil-
ity could be added to the roadmap;
• Two reviewers thought that the roadmap could be improved if it was more
flexible and that the methods suggested for implementing traceability should
be marked as exemplar;
• Five comments were made with regard to the applicability of some of the
content in the roadmap. These comments questioned the best practice of not
using traceability in performance reviews, and if there is a need for a Stand-
ard Operating Procedure;
• Six comments were made with regard to adding additional content to the
roadmap. These comments included adding additional columns to the trace
matrix, adding a section stating how the roadmap is applicable to different
SDLC types e.g. Agile, Spiral, Iterative, and finally one reviewer thought
that ‘in order to be persuasive it is important to sell traceability’ .
The Rationale column contained 6 comments relating to the reviewers understand-
ing of the roadmap and are summarised as:
• One reviewer thought that the roadmap could be improved with better ‘sign-
posting’ to direct the reader through the document;
• Three reviewers thought that the Overview section was not self-explanatory
and needed more detail;
• One reviewer was confused with the terms best practice and base practice;
• One reviewer considers that the rationale for traceability in the Introduction
section could be improved.
5.3 Discussion
As a result of the comments/suggestions for improvement the focus group, which
was convened after all the comments were received, came to a decision regarding
changes to be made to the roadmap. The changes are listed under the Structure, Con-
tent and Rationale categories.
Structure Category: One comment thought that references to the standards which
were in Section 2 of the roadmap should be put in an Appendix. This comment is
related to six other comments categorised under the Content column which refer to
the roadmap having too much content. The focus group agreed that the references to
the regulations were not necessary for the implementation of the roadmap and were
for informative purposes only and so agreed that they should be put in an appendix.
Two comments thought that the Introduction to the roadmap should contain
the benefits of traceability. These comments relate to a comment under the Content
category which states that it is important to sell traceability, and also relates to a
comment under the Rationale column which states that the rationale for traceability in
the Introduction could be improved. The focus group considered that putting the bene-
fits of traceability in the Introduction would inappropriately extend the Introduction.
It was agreed that the benefits and barriers section should be moved to an Appendix
and referenced in the Introduction.
Content Category: Six comments under the Content section stated that the use of
automatic tools should be encouraged more (as against manual methods which were
described in Section 2 of the roadmap). These comments are related to two other
comments under the Content section which state that the manual methods should be
marked as exemplar. The focused group agreed with these comments and so the man-
ual methods are marked as exemplar and moved to an appendix, which has the addi-
tional benefit of making the roadmap less complex. Additionally the use of automated
trace tools will be highlighted in the roadmap overview along with a tool decision
flowchart in Appendix D.
Three comments stated that a number of additional benefits of traceability
could be added to Figure 1 e.g. benefits 5, 6 and 7 should be added to Change Man-
agement. The focus group considered that these three benefits were generic across the
three processes and so it was agreed to add them to the three processes.
A number of comments were made with regard to adding additional content
to the roadmap. The focus group considered these comments and agreed to add a par-
agraph in the Introduction to address how the roadmap is applicable to different
SDLC types e.g. Iterative, Spiral, Agile etc.
Rationale Category: The focus group agreed that adding hyperlinks to the roadmap
would improve the readability of the document. This was in response to one review-
er’s comment about improving the ‘signposting’ throughout the roadmap.
One reviewer stated that using the two terms ‘best practice’ and ‘base practice’
was confusing. The focus group agreed not to change these terms as ‘base practice’ is
the term used in ISO/IEC 15504 and this is the standard on which the PAM related to
this roadmap complies with. Additionally the term ‘best practice’ is a term used
throughout the literature and is generally known. It was however agreed that a distinc-
tion between the terms should be made in the Introduction of the roadmap.
5.4 Complete Roadmap
A table of contents of the completed roadmap is shown in Table 3. The main body
of the roadmap now contains four relatively short sections with a lot of informative
material referenced in the Appendix.
Table 3 Completed Roadmap Table of Contents
Introduction Section 4
Barriers and possible solutions
Leveraging traceability benefits
Scope Appendix A
Difference between IEC 62304 and ISO
12207
Section 1 Roadmap Overview Appendix B
Traceability links and references to
Standards
Section 2 Traceability Milestones, Out-
comes and Base Practices for each of the
processes:
Change management
Risk management
SDLC
Appendix C
Exemplar traceability methods and tasks
Section 3 Implementation Case Study Appendix D
Traceability Best Practices in detail
6 Conclusion
To assist medical device organisations improve their traceability, a roadmap for the
implementation of traceability has been developed. This roadmap is based on a
ISO/IEC 15504 compliant Process Assessment Model (PAM) developed by the au-
thors prior to this roadmap. The PAM will assist medical device organisations un-
derstand their actual traceability performance and management of activities, and the
potential for improvement. The roadmap will then provide the pathway to that im-
provement and ensure compliance with the medical device standards and traceability
best practices.
Eight experts reviewed the roadmap. While the response was mostly positive they
made a total of forty two comments suggesting fourteen areas for change. A focus
group reviewed these comments and through consensus agreed to make two changes
to the structure of the roadmap, four changes to the content of the roadmap, and two
changes to aid understanding (rationale) of the roadmap. Based on the review feed-
back and resulting amendments which have resulted in its enhancement, the roadmap
is now ready for pilot assessment within two medical device organisations.
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